Nearly two decades of research and innovation are allowing us to revolutionize brain health and be recognized for it.
Learn more about our announcements and newsworthy achievements as we continue to build the world’s first precision neurology platform.
Women’s Brain Project and Altoida Announce Results Highlighting Sex-Based Differences Using Predictive Digital Biomarker in Alzheimer’s Disease
Mission Based Media Launches Alzheimer's Podcast, the Newest Podcast Miniseries on Health Unmuted™
Altoida Appoints Neuroscience Pioneer Dr. Antontella Santuccione Chadha as Chief Medical Officer
Altoida Announces Partnership with Click Therapeutics to Power Clinical Trials with Digital Cognitive Assessment
Altoida Partners With GN Group to Research and Develop New Cognitive Assessment Technology to Detect Mild Cognitive Impairment
Altoida Named to the 2021 CB Insights Digital Health 150 -- List of Most Innovative Digital Health Startups
Altoida and Ionian University Investigate Breakthrough Software Device for Parkinson's Disease Diagnosis
Altoida Receives Investment from Alzheimer’s Drug Discovery Foundation’s Diagnostics Accelerator to Advance Precision Neurology
Altoida Awarded FDA Breakthrough Designation for Development of World’s First Precision Neurology Device for Prediction of Alzheimer's Disease
Altoida Named to the 2021 CB Insights Digital Health 150 List of Most Innovative Digital Health Startups
Altoida Secures Funding and Research Partnership with Eisai Innovation to Accelerate Work Towards Predictive Dementia Diagnostics
Altoida Inc. Secures Investment from Hikma Ventures to Drive Better Clinical Outcomes for Brain Diseases
Using augmented reality, Altoida is identifying the likely onset of neurodegenerative diseases